) OVA sequence (323-336) |
|||
| TP1612-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: OVA sequence (323-336) |
|||
OVA sequence (323-336) |
|||
| TP1612-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: OVA sequence (323-336) |
|||
OVA sequence (323-336) |
|||
| TP1612-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: OVA sequence (323-336) |
|||
OVA sequence (323-336) |
|||
| TP1612-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: OVA sequence (323-336) |
|||
OVA sequence (323-336) |
|||
| TP1612-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: OVA sequence (323-336) |
|||
 Sekdel sequence |
|||
| MBS5784103-5mg | MyBiosource | 5(mg | EUR 915 |
Sekdel sequence |
|||
| MBS5784103-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
Sekdel sequence |
|||
| T34601-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Sekdel sequence |
|||
Sekdel sequence |
|||
| T34601-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Sekdel sequence |
|||
Sekdel sequence |
|||
| T34601-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Sekdel sequence |
|||
Sekdel sequence |
|||
| T34601-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Sekdel sequence |
|||
Sekdel sequence |
|||
| T34601-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Sekdel sequence |
|||
) Anantin (linear sequence) |
|||
| 5-00672 | CHI Scientific | 4 x 1mg | EUR 278.46 |
|
Description: Gly-Phe-Ile-Gly-Trp-Gly-Asn-Asp-Ile-Phe-Gly-His-Tyr-Ser-Gly-Asp-Phe (Peptide beta bond between Gly1-Asp8 ) |
|||
 C5a Inhibitory Sequence |
|||
| H-8135.0005 | Bachem | 5.0mg | EUR 849.6 |
|
Description: Sum Formula: C51H86N12O9; CAS# [133214-60-5] |
|||
C5a Inhibitory Sequence |
|||
| H-8135.0025 | Bachem | 25.0mg | EUR 3286.8 |
|
Description: Sum Formula: C51H86N12O9; CAS# [133214-60-5] |
|||
Anantin (linear sequence) |
|||
| H-8140.0001 | Bachem | 1.0mg | EUR 691.2 |
|
Description: Sum Formula: C90H113N21O25; CAS# [348600-37-3] net |
|||
Anantin (linear sequence) |
|||
| H-8140.0005 | Bachem | 5.0mg | EUR 2648.4 |
|
Description: Sum Formula: C90H113N21O25; CAS# [348600-37-3] net |
|||
 iLenti Sequence Primers |
|||
| LV012 | ABM | 100 μl (10 μM) | EUR 75 |
Anantin (linear sequence) |
|||
| MBS658367-10mg | MyBiosource | 10mg | EUR 970 |
Anantin (linear sequence) |
|||
| MBS658367-1mg | MyBiosource | 1mg | EUR 345 |
Anantin (linear sequence) |
|||
| MBS658367-5mg | MyBiosource | 5mg | EUR 680 |
Anantin (linear sequence) |
|||
| MBS658367-5x10mg | MyBiosource | 5x10mg | EUR 4210 |
) Anantin (Linear sequence) |
|||
| MBS8246085-10mg | MyBiosource | 10mg | EUR 4960 |
Anantin (Linear sequence) |
|||
| MBS8246085-1mg | MyBiosource | 1mg | EUR 1390 |
Anantin (Linear sequence) |
|||
| MBS8246085-5mg | MyBiosource | 5mg | EUR 3330 |
Anantin (Linear sequence) |
|||
| MBS8246085-5x10mg | MyBiosource | 5x10mg | EUR 22230 |
 LL - 37, reverse sequence |
|||
| 5-01471 | CHI Scientific | 4 x 1mg | EUR 371.28 |
|
Description: Ser-Glu-Thr-Arg-Pro-Val-Leu-Asn-Arg-Leu-Phe-Asp-Lys-Ile-Arg-Gln-Val-Ile-Arg-Lys-Phe-Glu-Lys-Gly-Ile-Lys-Glu-Lys-Ser-Lys-Arg-Phe-Phe-Asp-Gly-Leu-Leu |
|||
 Sequence Callout & Comparison |
|||
| 15-1001-14 | Gene Link | 1 Each | Ask for price |
 LL-37, reverse sequence |
|||
| MBS8246732-10mg | MyBiosource | 10mg | EUR 1540 |
LL-37, reverse sequence |
|||
| MBS8246732-1mg | MyBiosource | 1mg | EUR 475 |
LL-37, reverse sequence |
|||
| MBS8246732-5mg | MyBiosource | 5mg | EUR 1065 |
LL-37, reverse sequence |
|||
| MBS8246732-5x10mg | MyBiosource | 5x10mg | EUR 6855 |
 ACES™ Signal Sequence Kit |
|||
| 0148-2 | AthenaES | kit | EUR 264 |
 Substance P reversed sequence |
|||
| 5-01970 | CHI Scientific | 4 x 5mg | EUR 270.27 |
|
Description: Met-Leu-Gly-Phe-Phe-Gln-Gln-Pro-Lys-Pro-Arg-NH2 |
|||
 Peptide) Anantin (linear sequence) Peptide |
|||
| abx266971-1ml | Abbexa | 1 ml | EUR 762.5 |
Anantin (linear sequence) Peptide |
|||
| abx266971-200l | Abbexa | 200 µl | EUR 325 |
 LL 37, reverse sequence Peptide |
|||
| abx267003-1ml | Abbexa | 1 ml | EUR 975 |
LL 37, reverse sequence Peptide |
|||
| abx267003-200l | Abbexa | 200 µl | EUR 400 |
 Protein Kinase, Consensus Sequence |
|||
| MBS614458-1mL | MyBiosource | 1mL | EUR 540 |
Protein Kinase, Consensus Sequence |
|||
| MBS614458-5x1mL | MyBiosource | 5x1mL | EUR 2275 |
 a2b1 Integrin Recognition Sequence |
|||
| H-1376.0025 | Bachem | 25.0mg | EUR 691.2 |
|
Description: Sum Formula: C14H22N4O9; CAS# [134580-64-6] |
|||
a2b1 Integrin Recognition Sequence |
|||
| H-1376.0100 | Bachem | 100.0mg | EUR 1995.6 |
|
Description: Sum Formula: C14H22N4O9; CAS# [134580-64-6] |
|||
 LI-37 Reverse Sequence Peptide |
|||
| PE-88325 | Novatein Biosciences, Inc. |
|
|
 Prostamax TFA salt, sequence: KEDP |
|||
| O038-20 | SW Technology Co., Ltd | 20 mg | Ask for price |
 Synthetic HIV-2 gp 36 Sequence |
|||
| VAng-0535Lsx-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: HIV type 2 glycoprotein 36, chemically synthesized polypeptide containing immunodominant region of the HIV-2 envelope. 1.00 mg/mL. |
|||
 Enkephalin Sequence, Tyr-Gly-Gly |
|||
| MBS657933-1mg | MyBiosource | 1mg | EUR 610 |
Enkephalin Sequence, Tyr-Gly-Gly |
|||
| MBS657933-5x1mg | MyBiosource | 5x1mg | EUR 2600 |
 Signal Sequence Receptor, beta Antibody |
|||
| 20-abx137475 | Abbexa |
|
|
 Substance P reversed sequence Peptide |
|||
| abx266314-100l | Abbexa | 100 µl | EUR 312.5 |
Substance P reversed sequence Peptide |
|||
| 20-abx266314 | Abbexa |
|
|
Substance P reversed sequence Peptide |
|||
| abx266314-1ml | Abbexa | 1 ml | EUR 812.5 |
Substance P reversed sequence Peptide |
|||
| abx266314-200l | Abbexa | 200 µl | EUR 462.5 |
 Breast Carcinoma Amplified Sequence 2 |
|||
| PR27246 | Neuromics | 5 ug | EUR 97.2 |
Breast Carcinoma Amplified Sequence 2 |
|||
| PR27246-B | Neuromics | each | EUR 184.5 |
-Human noncoding mRNA sequence) (untagged)-Human noncoding mRNA sequence |
|||
| SC312200 | Origene Technologies GmbH | 10 µg | Ask for price |
 Substance P Reversed Sequence Peptide |
|||
| PE-87368 | Novatein Biosciences, Inc. |
|
|
 Signal Sequence Receptor, alpha Antibody |
|||
| 20-abx115551 | Abbexa |
|
|
Signal Sequence Receptor, alpha Antibody |
|||
| abx115551-500g | Abbexa | 500 µg | EUR 612.5 |
 Recombinant Human HSP70, native sequence |
|||
| MBS806938-005mg | MyBiosource | 0.05mg | EUR 375 |
Recombinant Human HSP70, native sequence |
|||
| MBS806938-01mg | MyBiosource | 0.1mg | EUR 475 |
Recombinant Human HSP70, native sequence |
|||
| MBS806938-2x01mg | MyBiosource | 2x0.1mg | EUR 795 |
Recombinant Human HSP70, native sequence |
|||
| MBS806938-5x005mg | MyBiosource | 5x0.05mg | EUR 1425 |
Recombinant Human HSP70, native sequence |
|||
| MBS806938-5x01mg | MyBiosource | 5x0.1mg | EUR 1890 |
 Recombinant Human HSP27, native sequence |
|||
| MBS806966-005mg | MyBiosource | 0.05mg | EUR 270 |
Recombinant Human HSP27, native sequence |
|||
| MBS806966-01mg | MyBiosource | 0.1mg | EUR 375 |
Recombinant Human HSP27, native sequence |
|||
| MBS806966-2x01mg | MyBiosource | 2x0.1mg | EUR 510 |
Recombinant Human HSP27, native sequence |
|||
| MBS806966-5x005mg | MyBiosource | 5x0.05mg | EUR 965 |
Recombinant Human HSP27, native sequence |
|||
| MBS806966-5x01mg | MyBiosource | 5x0.1mg | EUR 1410 |
-Human clone 23887 mRNA sequence) (untagged)-Human clone 23887 mRNA sequence |
|||
| SC105816 | Origene Technologies GmbH | 10 µg | Ask for price |
-Human clone 24686 mRNA sequence) (untagged)-Human clone 24686 mRNA sequence |
|||
| SC105851 | Origene Technologies GmbH | 10 µg | Ask for price |
-Human clone 24870 mRNA sequence) (untagged)-Human clone 24870 mRNA sequence |
|||
| SC106263 | Origene Technologies GmbH | 10 µg | Ask for price |
-Human clone 24741 mRNA sequence) (untagged)-Human clone 24741 mRNA sequence |
|||
| SC106466 | Origene Technologies GmbH | 10 µg | Ask for price |
-Human clone 24674 mRNA sequence) (untagged)-Human clone 24674 mRNA sequence |
|||
| SC312347 | Origene Technologies GmbH | 10 µg | Ask for price |
) LL-37, reverse sequence (synthetic >95%) |
|||
| SP-88325-1 | Alpha Diagnostics | 1 mg | EUR 416.4 |
 Anti-Protein Kinase Consensus Sequence |
|||
| MBS480071-1mL | MyBiosource | 1mL | EUR 320 |
Anti-Protein Kinase Consensus Sequence |
|||
| MBS480071-5x1mL | MyBiosource | 5x1mL | EUR 1220 |
 Erythropoietin Mimetic Peptide Sequence 20 |
|||
| H-4344.0001 | Bachem | 1.0mg | EUR 544.8 |
|
Description: Sum Formula: C72H99N17O17S2; CAS# [203397-62-0] net |
|||
Erythropoietin Mimetic Peptide Sequence 20 |
|||
| H-4344.0005 | Bachem | 5.0mg | EUR 2067.6 |
|
Description: Sum Formula: C72H99N17O17S2; CAS# [203397-62-0] net |
|||
 Enkephalin Sequence, Tyr-Gly-Gly-Phe |
|||
| MBS658304-1mg | MyBiosource | 1mg | EUR 610 |
Enkephalin Sequence, Tyr-Gly-Gly-Phe |
|||
| MBS658304-5x1mg | MyBiosource | 5x1mg | EUR 2600 |
) Anti-Signal sequence receptor delta (2D3) |
|||
| YF-MA15624 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to Signal sequence receptor delta |
|||
 Malignant T-cell-amplified sequence 1 |
|||
| AP79055 | SAB | 1mg | EUR 2640 |
 Antibody) TPA-Induced Sequence 11b (TIS11B) Antibody |
|||
| abx375201-96tests | Abbexa | 96 tests | EUR 337.5 |
Malignant T-cell-amplified sequence 1 |
|||
| AP85696 | SAB | 1mg | EUR 2640 |
Malignant T-cell-amplified sequence 1 |
|||
| AP85136 | SAB | 1mg | EUR 2640 |
Malignant T-cell-amplified sequence 1 |
|||
| AP85389 | SAB | 1mg | EUR 2640 |
Malignant T-cell-amplified sequence 1 |
|||
| AP85421 | SAB | 1mg | EUR 2640 |
TPA-Induced Sequence 11b (TIS11B) Antibody |
|||
| 20-abx219410 | Abbexa |
|
|
 Recombinant M. bovis HSP65, native sequence |
|||
| MBS806961-005mg | MyBiosource | 0.05mg | EUR 350 |
Recombinant M. bovis HSP65, native sequence |
|||
| MBS806961-01mg | MyBiosource | 0.1mg | EUR 445 |
Recombinant M. bovis HSP65, native sequence |
|||
| MBS806961-2x01mg | MyBiosource | 2x0.1mg | EUR 745 |
Recombinant M. bovis HSP65, native sequence |
|||
| MBS806961-5x005mg | MyBiosource | 5x0.05mg | EUR 1310 |
Recombinant M. bovis HSP65, native sequence |
|||
| MBS806961-5x01mg | MyBiosource | 5x0.1mg | EUR 1750 |
 Antibody) Neuroblastoma Amplified Sequence (NBAS) Antibody |
|||
| abx003586-100l | Abbexa | 100 µl | EUR 400 |
Neuroblastoma Amplified Sequence (NBAS) Antibody |
|||
| 20-abx003586 | Abbexa |
|
|
Neuroblastoma Amplified Sequence (NBAS) Antibody |
|||
| abx003586-20l | Abbexa | 20 µl | EUR 175 |